For the year ending 2025-12-31, EKSO had -$5,324K decrease in cash & cash equivalents over the period. -$11,989K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -11,695 |
| Depreciation and amortization | 1,573 |
| Loss on impairment of intangible assets | 750 |
| Changes in provision for credit losses on accounts receivable | -50 |
| Common stock contribution to 401 plan | 151 |
| Stock-based compensation expense | 1,474 |
| Gain on revaluation of warrant liabilities | 1 |
| Loss on modification of warrant | 0 |
| Unrealized (gain) loss on foreign currency transactions | 1,965 |
| Accounts receivable | -446 |
| Inventories | 275 |
| Prepaid expenses and other assets current and noncurrent | 187 |
| Accounts payable | -137 |
| Accrued, lease and other current and noncurrent liabilities | -1,102 |
| Deferred revenues | -783 |
| Net cash used in operating activities | -11,801 |
| Acquisition of property and equipment | 188 |
| Net cash used in investing activities | -188 |
| Principal payments under note payable | 1,250 |
| Retirement of term loan-Term Loan | 2,000 |
| Proceeds from issuance of common stock, net | 4,098 |
| Proceeds from exercise of warrants, net | 3,856 |
| Proceeds from issuance of convertible promissory note, net-Promissory Note | 1,925 |
| Net cash provided by financing activities | 6,629 |
| Effect of exchange rate changes on cash | 36 |
| Net decrease in cash | -5,324 |
| Cash and restricted cash at beginning of the year | 6,493 |
| Cash and restricted cash at end of the year | 1,169 |
EKSO BIONICS HOLDINGS, INC. (EKSO)
EKSO BIONICS HOLDINGS, INC. (EKSO)